Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-05-15

Clinical Trial Update: Adjunctive Usage of a Moisturizing Lotion (Cetaphil® Moisturizing Lotion) to Limit the Skin Irritation Linked to the Set-Up of a Treatment by Topical Retinoid (Differin® Gel 0,1%) in Healthy Subjects of Chinese Origins [Phase 4]

View source ↗

Summary

Phase 4 trial assessing adjunctive use of Cetaphil moisturizing lotion to reduce skin irritation from topical retinoid (Differin gel) in healthy Chinese-origin …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cetaphil Moisturizing Lotion
  • DIFFERIN (ADAPALENE)

Snippet

Sponsor: Galderma R&D | Conditions: Healthy Skin | Phase 4 | Status: COMPLETED | Results posted: 2012-05-15